Explainambiguity Think Tank is part of the Drug Target Review Advisory Board
Explainambiguity Think Tank is dedicated to addressing the complexities and ambiguities inherent in the integration of Artificial Intelligence (AI) within the pharmaceutical and healthcare sectors.
Our mission is to provide clarity, foster innovation, and ensure regulatory compliance by tackling the root causes of ambiguity in AI applications. By doing so, we aim to drive business success through enhanced transparency, trust, and efficiency.
Join us in our mission to clarify the ambiguous, ensuring a safer, more efficient, and innovative healthcare landscape. Together, we can transform challenges into opportunities for growth and improvement, driving business success through AI clarity.
Beyond serendipity: rational design and AI’s expansion of the undruggable target landscape
Drug Target Review · February 6, 2026For decades, drugging the ‘undruggable’ was thought to require luck rather than logic. Today, AI is transforming serendipity into strategy by enabling rational, data-driven approaches to previously inaccessible targets.Token-Level Attribution for Transparent Biomedical AI
Biomedical Engineering and Computational Biology · January 17, 2026BIOTECHGATE DIGITAL PARTNERING
Feb 23-27, 2026